» Articles » PMID: 15661743

Role of Protein Phosphatase 2A in MGluR5-regulated MEK/ERK Phosphorylation in Neurons

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2005 Jan 22
PMID 15661743
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

The regulation of protein phosphorylation requires coordinated interaction between protein kinases and protein phosphatases (PPs). Recent evidence has shown that the Galphaq-protein-coupled metabotropic glutamate receptor (mGluR) 5 up-regulates phosphorylation of MAPK/ERK1/2. However, signaling mechanisms linking mGluR5 to ERK are poorly understood. In this study, roles of a major serine/threonine PP, PP2A, in this event were evaluated in cultured neurons. We found that the PP1/2A inhibitors okadaic acid and calyculin A mimicked the effect of the mGluR5 agonists (RS)-3,5-dihydroxyphenylglycine and (RS)-2-chloro-5-hydroxyphenylglycine in facilitating phosphorylation of ERK1/2 and its upstream kinase, MEK1/2, in a PP2A-dependent but not PP1-dependent manner. Co-administration of either inhibitor with an mGluR5 agonist produced additive phosphorylation of ERK1/2. Enzymatic assays showed a basal level of phosphatase activity of PP2A under normal conditions, and activation of mGluR5 selectively inhibited PP2A, but not PP1, activity. In addition, a physical association of the cytoplasmic C terminus of mGluR5 with PP2A was observed, and ligand activation of mGluR5 reduced mGluR5-PP2A binding. Additional mechanistic studies revealed that mGluR5 activation increased tyrosine (Tyr307) phosphorylation of PP2A, which was dependent on activation of a p60c-Src family tyrosine kinase, but not the epidermal growth factor receptor tyrosine kinase and resulted in dissociation of PP2A from mGluR5 and reduced PP2A activity. Together, we have identified a novel, mGluR5-triggered signaling mechanism involving use- and Src-dependent inactivation of PP2A, which contributes to mGluR5 activation of MEK1/2 and ERK1/2.

Citing Articles

Pharmacology, Signaling and Therapeutic Potential of Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators.

Kos J, Langiu M, Hellyer S, Gregory K ACS Pharmacol Transl Sci. 2024; 7(12):3671-3690.

PMID: 39698283 PMC: 11651194. DOI: 10.1021/acsptsci.4c00213.


Sturge-Weber syndrome: updates in translational neurology.

Solomon C, Comi A Front Neurol. 2024; 15:1493873.

PMID: 39687400 PMC: 11646805. DOI: 10.3389/fneur.2024.1493873.


Mapping the substrate landscape of protein phosphatase 2A catalytic subunit PPP2CA.

Brewer A, Sathe G, Pflug B, Clarke R, Macartney T, Sapkota G iScience. 2024; 27(3):109302.

PMID: 38450154 PMC: 10915630. DOI: 10.1016/j.isci.2024.109302.


Functional Dimerization of Serotonin Receptors: Role in Health and Depressive Disorders.

Mitroshina E, Marasanova E, Vedunova M Int J Mol Sci. 2023; 24(22).

PMID: 38003611 PMC: 10671093. DOI: 10.3390/ijms242216416.


Precise timing of ERK phosphorylation/dephosphorylation determines the outcome of trial repetition during long-term memory formation.

Kukushkin N, Tabassum T, Carew T Proc Natl Acad Sci U S A. 2022; 119(40):e2210478119.

PMID: 36161885 PMC: 9546540. DOI: 10.1073/pnas.2210478119.